Muscle weakness means reduced ability to generate normal force and can have many causes. The first distinction is between true weakness and fatigue, pain-limited movement or reduced physical conditioning. True weakness results from dysfunction somewhere in the motor system, which includes the brain, spinal cord, peripheral nerves, neuromuscular junctions and muscles themselves. Weakness can be generalised or confined to particular muscles or body regions. It may develop suddenly, gradually, intermittently or progressively. The pattern provides important diagnostic information. For example, weakness affecting one side suddenly may suggest a central neurological emergency, while weakness that predominantly affects proximal muscles may suggest a muscle disorder or certain neuromuscular conditions. (nhs.uk)
Neurological causes include disorders of the brain and spinal cord. Stroke can produce sudden weakness, often affecting one side of the body and sometimes accompanied by facial drooping, speech disturbance or sensory changes. Spinal cord compression or injury can cause weakness below the affected level, sometimes accompanied by altered sensation or bladder and bowel dysfunction. Multiple sclerosis and other neurological diseases can produce weakness through damage to central nervous-system pathways. Because the central nervous system carries the commands required for voluntary movement, damage anywhere along these pathways can reduce effective muscle activation even though the muscle fibres themselves may remain structurally intact. Sudden weakness, particularly with facial or speech symptoms, requires emergency assessment.
Peripheral nerve disorders can cause weakness in the muscles supplied by affected nerves. Nerve compression, such as a spinal nerve-root problem, can produce weakness together with pain, numbness or tingling. Peripheral neuropathies can result from diabetes, nutritional deficiencies, toxins, certain medicines, inherited disorders and other causes. Motor-neuron diseases affect nerve cells responsible for voluntary muscle control and can cause progressive weakness, muscle wasting, cramps and fasciculations. Spinal muscular atrophy is a genetic disorder in which motor neurons degenerate, producing progressive weakness and muscle wasting. The combination of weakness with muscle twitching or atrophy can therefore be clinically important and may warrant neurological investigation.
The neuromuscular junction is another possible site of dysfunction. Myasthenia gravis is an autoimmune disorder in which antibodies interfere with proteins involved in transmission between motor nerves and muscles. Acetylcholine normally binds receptors on muscle fibres and initiates contraction, but in myasthenia gravis this communication is impaired. Weakness characteristically fluctuates and can worsen with repeated use, often affecting the eyes, eyelids, facial muscles, swallowing muscles or limb muscles. Other neuromuscular-junction disorders can produce similar patterns. This demonstrates that a weak muscle is not necessarily diseased itself; the failure may occur in the communication system between the nerve and muscle.
Primary muscle disorders can directly impair force production. Muscular dystrophies are inherited conditions involving abnormal muscle proteins and progressive muscle fibre damage, while inflammatory myopathies can cause weakness through immune-mediated muscle inflammation. Metabolic and mitochondrial disorders can impair the energy supply required for contraction. Endocrine abnormalities, including some thyroid disorders and hormonal disturbances, can also affect muscle performance. Severe nutritional deficiency, prolonged inactivity and significant loss of muscle mass can produce weakness without a primary neurological disease. The distribution and tempo of weakness, associated pain, wasting, reflex changes and laboratory findings help distinguish among these possibilities.
Medications and systemic illnesses can also produce weakness. Some drugs affect muscle directly, interfere with neuromuscular transmission or alter electrolyte balance. Severe infection, prolonged hospitalisation, critical illness and extended immobilisation can lead to rapid loss of muscle strength. Electrolyte abnormalities involving potassium, calcium or other minerals can impair muscle and nerve function. Anaemia and cardiopulmonary disease can produce a sensation of reduced physical capacity that may be described as weakness even when neurological strength is preserved. Careful history taking is therefore essential, including medication changes, recent illness, nutrition, exercise level and the precise circumstances in which weakness occurs.
The pattern of weakness can help localise its cause. Proximal weakness, affecting muscles around the hips and shoulders, is common in several muscle disorders and can cause difficulty rising from a chair, climbing stairs or lifting objects overhead. Distal weakness affects hands, feet or other muscles farther from the trunk and is common in some peripheral neuropathies. Fluctuating weakness suggests possibilities such as neuromuscular-junction disorders, while progressive weakness with wasting and fasciculations can suggest motor-neuron or muscle disease. Sudden focal weakness suggests a potentially acute neurological process. These patterns are clues rather than diagnoses, because several diseases can produce overlapping presentations.
Medical assessment is particularly important for unexplained, progressive or functionally significant weakness. Sudden weakness requires emergency assessment, especially when it affects one side of the body or occurs with speech, facial, breathing or swallowing problems. Gradually progressive weakness, muscle wasting, persistent twitching or weakness accompanied by sensory symptoms should also be assessed. Investigations may include neurological examination, blood tests for metabolic and muscle abnormalities, nerve conduction studies, electromyography, imaging, genetic testing or other specialist investigations. The appropriate test depends on the suspected anatomical level and clinical pattern. Weakness should therefore be treated as a symptom requiring localisation and explanation rather than as a diagnosis by itself.
